Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion

JOURNAL ARTICLE published 1 November 2020 in Expert Opinion on Pharmacotherapy

Authors: Sven G. Meuth | Antonios Bayas | Boris Kallmann | Christoph Kleinschnitz | Ralf Linker | Peter Rieckmann | Mathias Mäurer

Treating pain in multiple sclerosis

JOURNAL ARTICLE published October 2011 in Expert Opinion on Pharmacotherapy

Authors: Andrea Truini | Francesca Galeotti | Giorgio Cruccu

Irinotecan and bevacizumab in recurrent glioblastoma multiforme

JOURNAL ARTICLE published April 2011 in Expert Opinion on Pharmacotherapy

Authors: Jan Nyrop Jakobsen | Benedikte Hasselbalch | Marie-Thérése Stockhausen | Ulrik Lassen | Hans Skovgaard Poulsen

Oxycodone for the treatment of postoperative pain

JOURNAL ARTICLE published May 2012 in Expert Opinion on Pharmacotherapy

Authors: Hannu Kokki | Merja Kokki | Sari Sjövall

Pharmaceutical management of sexual dysfunction in men on antidepressant therapy

JOURNAL ARTICLE published 13 June 2022 in Expert Opinion on Pharmacotherapy

Authors: Ahmed M. Bakr | Amro A. El-Sakka | Ahmed I. El-Sakka

Advances in chemical pharmacotherapy to manage advanced breast cancer

JOURNAL ARTICLE published 2 January 2017 in Expert Opinion on Pharmacotherapy

Authors: Andrea Gombos | Ahmad Awada

Bexagliflozin for type 2 diabetes: an overview of the data

JOURNAL ARTICLE published 2 November 2021 in Expert Opinion on Pharmacotherapy

Authors: Omar Azzam | Revathy Carnagarin | Leslie Marisol Lugo-Gavidia | Janis Nolde | Vance B. Matthews | Markus P. Schlaich

An evaluation of lumateperone tosylate for the treatment of schizophrenia

JOURNAL ARTICLE published 22 January 2020 in Expert Opinion on Pharmacotherapy

Authors: Pankhuri Vyas | Brian Jaeho Hwang | James Robert Brašić

Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease

JOURNAL ARTICLE published 12 October 2016 in Expert Opinion on Pharmacotherapy

Research funded by Healthy Ageing Research Centre project (REGPOT-2012-2013-1,7FP)

Authors: Jacek Rysz | Anna Gluba-Brzózka | Beata Franczyk | Maciej Banach | Piotr Bartnicki

Current perspectives on pharmacotherapy of Alzheimer's disease

JOURNAL ARTICLE published February 2011 in Expert Opinion on Pharmacotherapy

Authors: Kanwaljit Chopra | Shubham Misra | Anurag Kuhad

Cytomegalovirus treatment options in immunocompromised patients

JOURNAL ARTICLE published August 2001 in Expert Opinion on Pharmacotherapy

Authors: Mike Sharland | Milind D Khare

Capecitabine for the treatment of pancreatic cancer

JOURNAL ARTICLE published 4 March 2019 in Expert Opinion on Pharmacotherapy

Authors: Nauman S. Siddiqui | Amandeep Godara | Margaret M. Byrne | Muhammad Wasif Saif

What are the key challenges in the pharmacological management of cholangiocarcinoma?

JOURNAL ARTICLE published 24 March 2022 in Expert Opinion on Pharmacotherapy

Authors: Matthew Ledenko | Tushar Patel

State-of-the-art pharmacotherapy for diabetic neuropathy

JOURNAL ARTICLE published 2 January 2021 in Expert Opinion on Pharmacotherapy

Authors: Shazli Azmi | Uazman Alam | Jamie Burgess | Rayaz A. Malik

Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis

JOURNAL ARTICLE published April 2007 in Expert Opinion on Pharmacotherapy

Authors: Christina Lee | Jonathan Corren

New facets of androgen replacement therapy during childhood and adolescence

JOURNAL ARTICLE published July 2005 in Expert Opinion on Pharmacotherapy

Authors: Alan D Rogol

An update on antifungal resistance in dermatophytosis

JOURNAL ARTICLE published 17 April 2024 in Expert Opinion on Pharmacotherapy

Authors: Aditya K. Gupta | Avantika Mann | Shruthi Polla Ravi | Tong Wang

Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia

JOURNAL ARTICLE published November 2002 in Expert Opinion on Pharmacotherapy

Authors: James O’Donnell | David J Perry

Ulipristal acetate and its role in emergency contraception: a comment

JOURNAL ARTICLE published September 2012 in Expert Opinion on Pharmacotherapy

Authors: Panagiotis Peitsidis

Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?

JOURNAL ARTICLE published August 2003 in Expert Opinion on Pharmacotherapy

Authors: Sheila Doggrell